bronchopulmonary dysplasia
Finding the Optimal Postnatal Dexamethasone Regimen for Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Systematic Review of Placebo-Controlled Trials
13
Hair Nicotine Levels in Children With Bronchopulmonary Dysplasia
11
Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
6
Effects of Inspired Oxygen on Echocardiographic Assessment of Pulmonary Vascular Resistance and Myocardial Contractility in Bronchopulmonary Dysplasia
7
Normal Pulmonary Vascular Resistance and Left Ventricular Hypertrophy in Young Infants with Bronchopulmonary Dysplasia: An Echocardiographic and Pathologic Study
10
Cell Therapy: A Novel Treatment Approach for Bronchopulmonary Dysplasia
13
Long-Term Morbidity of Infants With Bronchopulmonary Dysplasia
11
Vitamin A Status and Postnatal Dexamethasone Treatment in Bronchopulmonary Dysplasia
9
Summary Proceedings From the Bronchopulmonary Dysplasia Group
7
Functional Impairment of the Brainstem in Infants With Bronchopulmonary Dysplasia
12
Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
11
Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
13
Heritability of Bronchopulmonary Dysplasia, Defined According to the Consensus Statement of the National Institutes of Health
9
Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia
14
Sudden Infant Death Syndrome in Infants With Bronchopulmonary Dysplasia
6
Nutrition of preterm infants in relation to bronchopulmonary dysplasia
6
Movement Disorder of Premature Infants With Severe Bronchopulmonary Dysplasia: A New Syndrome
6
Pepsin, a Marker of Gastric Contents, Is Increased in Tracheal Aspirates From Preterm Infants Who Develop Bronchopulmonary Dysplasia
9
Pharmacotherapy of bronchopulmonary dysplasia: modernity and perspective
8
Bronchopulmonary dysplasia - an overview about pathophysiologic concepts
7